Sun Pharmaceutical Industries’ subsidiary Caraco Pharmaceutical Laboratories has started recalling some batches of Venlafaxine Hydrochloride extended-release tablets from the US market. According to a notification by the USFDA, the recall of 26,530 units of 30-count bottles and 14,597 units of 90-count bottles is voluntarily initiated by the company through a letter to the regulator last month under 'Class-II' classification. Venlafaxine Hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder.
Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
